Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07527143 · ClinicalTrials.gov registry record
Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
A clinical trial, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 25
- Enrollment target
NCT07527143: Recruiting study, sponsored by Mayo Clinic.
NCT07527143 is a clinical trial that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07527143 is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
Study Summary
This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-06-10 |
| Est. Completion | 2027-06-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07527143
The ClinicalTrials.gov registry entry for NCT07527143 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT07527143 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07527143 about?
NCT07527143 is a clinical study titled "Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer". This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.
What is the current status of trial NCT07527143?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2026-06-10. Estimated completion is 2027-06-10.
What interventions are being tested in trial NCT07527143?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT07527143?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.